Electrospun nanofibers for customized drug-delivery systems

被引:165
|
作者
Kajdic, Sasa [1 ,2 ]
Planinsek, Odon [1 ]
Gasperlin, Mirjana [1 ]
Kocbek, Petra [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Askerceva Cesta 7, Ljubljana 1000, Slovenia
[2] Krka Dd, Smarjeska Cesta 6, Novo Mesto 8501, Slovenia
关键词
Nanofibers; Drug delivery; Electrospinning; Immediate drug release; Modified drug release; CORE-SHELL NANOFIBERS; ENHANCED WATER SOLUBILITY; CONTROLLED-RELEASE; IN-VITRO; POLYMERIC NANOFIBERS; SUSTAINED-RELEASE; CELLULOSE NANOFIBERS; INCLUSION COMPLEX; MATS; DISSOLUTION;
D O I
10.1016/j.jddst.2019.03.038
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanofiber-based drug-delivery systems are widely applicable for specific drug release, according to the target location and timing, to achieve the desired therapeutic effects. A nanofiber formulation is usually developed for a specific drug, and a change of drug can drastically affect the release kinetics from the same delivery system. Here, we review the various types of nanofibers from the latest available literature, based on their composition and drug-release properties. Nanofibers are characterized according to their mode of drug release, and according to their structure and composition. Nanofibers designed for immediate drug release have generally simple structures. A suitable polymer, large surface-to-volume ratio, and high porosity of the nanofiber mesh are exploited to achieve immediate drug release. Nanofibers for modified drug release are classified here according to their drug-release characteristics, as prolonged, stimulus-activated, and biphasic. In general, swellable or degradable polymers are used to modify the drug release. As well as the selection of the polymer, the process and environmental conditions can significantly influence the release properties of nanofibers. The formulation of nanofibers is very complex and depends on many variables, although at the same time, the design of the formulation offers many opportunities to achieve the desired nanofiber drug-release properties.
引用
收藏
页码:672 / 681
页数:10
相关论文
共 50 条
  • [1] Nanofibers as drug-delivery systems for antimicrobial peptides
    Sousa, Mauricio G. C.
    Rezende, Taia M. B.
    Franco, Octavio L.
    DRUG DISCOVERY TODAY, 2021, 26 (08) : 2064 - 2074
  • [2] Nanofibers as drug-delivery systems for infection control in dentistry
    Sousa, Mauricio G. C.
    Maximiano, Mariana R.
    Costa, Rosiane A.
    Rezende, Taia M. B.
    Franco, Octavio L.
    EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (07) : 919 - 930
  • [3] Functionalized nanofibers as drug-delivery systems for osteochondral regeneration
    Amler, Evzen
    Filova, Eva
    Buzgo, Matej
    Prosecka, Eva
    Rampichova, Michala
    Necas, Alois
    Nooeaid, Patcharakamon
    Boccaccini, Aldo R.
    NANOMEDICINE, 2014, 9 (07) : 1083 - 1094
  • [4] Therapeutic applications of electrospun nanofibers for drug delivery systems
    Son, Young Ju
    Kim, Woo Jin
    Yoo, Hyuk Sang
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (01) : 69 - 78
  • [5] Therapeutic applications of electrospun nanofibers for drug delivery systems
    Young Ju Son
    Woo Jin Kim
    Hyuk Sang Yoo
    Archives of Pharmacal Research, 2014, 37 : 69 - 78
  • [6] DRUG-DELIVERY SYSTEMS
    NIKANDER, K
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1994, 7 : S19 - S24
  • [7] Electrospun Nanofibers in Oral Drug Delivery
    Ignatious, Francis
    Sun, Linghong
    Lee, Chao-Pin
    Baldoni, John
    PHARMACEUTICAL RESEARCH, 2010, 27 (04) : 576 - 588
  • [8] Electrospun Nanofibers in Oral Drug Delivery
    Francis Ignatious
    Linghong Sun
    Chao-Pin Lee
    John Baldoni
    Pharmaceutical Research, 2010, 27 : 576 - 588
  • [9] Electrospun Nanofibers for Drug Delivery and Biosensing
    Cleeton, Conor
    Keirouz, Antonios
    Chen, Xianfeng
    Radacsi, Norbert
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2019, 5 (09) : 4183 - 4205
  • [10] ELECTROSPUN NANOFIBERS FOR TOPICAL DRUG DELIVERY
    Wagner, I.
    Pataki, H.
    Balogh, A.
    Nagy, Zs. K.
    Harasztos, A. H.
    Suhajda, A.
    Marosi, Gy.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 44 : 148 - 149